Navigation Links
Sequenom Announces Proposed Public Offering of Common Stock
Date:1/19/2012

SAN DIEGO, Jan. 19, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Jefferies & Company, Inc. is acting as sole book-running manager for the offering. 

The securities described above are being offered by Sequenom pursuant to a shelf registration statement previously filed with the Securities and Exchange Commission (the "SEC"), which the SEC declared effective on December 21, 2011. A preliminary prospectus supplement related to the offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to this offering, when available, may be obtained from Jefferies & Company, Inc., Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 12th floor, New York, NY 10022, or by telephone at 877-547-6340, or by email at Prospectus_Department@Jefferies.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutio
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
2. Sequenom Announces Paul Maier to Become Interim Chief Financial Officer
3. Sequenom Announces Addition to Clinical Advisory Board
4. Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit
5. Sequenom Announces Launch of SensiGene Fetal(XY) (Fetal Sex Determination) Test
6. Sequenom Reports 2009 Fourth Quarter and Full Year Financial Results
7. Sequenom Announces Final Approval of Settlement in Class Action Securities Lawsuit
8. Sequenom to Present at the Jefferies 2010 Global Life Sciences Conference
9. Sequenom Announces Date of Second Quarter 2010 Financial Results and Conference Call
10. Sequenom to Present at Two Financial Conferences in November
11. Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. ... company with a focus on Omega-3 therapies for cardiovascular ... 2015 it issued 763,752 common shares of the Corporation ... interest for the period of December 5 th , ... outstanding Convertible Notes that is due on or before ...
(Date:3/26/2015)... , March 26, 2015 "Whether it,s ... patients one day." In a single sentence, ... chief scientific officer at Pfizer,s Centers for Therapeutic ... and scientists fueling progress at America,s biopharmaceutical companies. ... work side-by-side with academia, patient foundations and the National ...
(Date:3/26/2015)... ROYAL OAK, Mich. , March 26, 2015 /PRNewswire/ ... have performed the Midwest,s first commercial implant ... Drug Administration for patients with non-valvular atrial fibrillation. The ... to long-term use of blood-thinning warfarin medication to reduce ... the most common heart rhythm disorder affecting more than ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3
... Proprietary DNA delivery technology enables sustained,Interferon-beta production ... mouse model of heart disease, NEW ORLEANS--(BUSINESS ... Clinic and presented today at the American ... that a single,administration of DNA encoding the ...
... statins for only five weeks at,400 mg/week lowered ... with similarly favorable effects on other,atherogenic lipids, NEW ... Isis Pharmaceuticals, Inc. announced new,results from its Phase ... presented today at the of Cardiology,Annual Scientific Session ...
Cached Medicine Technology:Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 2Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 2Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 4Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 5Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 6Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 7Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 8Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 9
(Date:3/28/2015)... Take a bite of warm, gooey pepperoni ... tumble into the stomach, ready to break down your ... these acids run amok, triggering a burning sensation in ... than 60 million Americans have heartburn at least once ... and how it can be stopped. , Heartburn or ...
(Date:3/28/2015)... York, NY (PRWEB) March 28, 2015 ... that offers urgent care in Manhattan, recently commemorated its ... care facility in Manhattan. In addition to 24-hour urgent ... ER facilities. , At this time, Emergency Medical ... for abdominal pain, asthma, chest pain, eye injuries, ear ...
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple ... injuries, according to new research released today at the American ... , “Our findings indicate that a 10 inch increase in ... a history of injury, a 10 mile per hour increase ... a history of injury, and playing for more than one ...
(Date:3/28/2015)... Early surgery may not be the ... joint injuries, according to new research from Tripler Army ... Orthopaedic Society for Sports Medicine’s ( AOSSM ) Specialty ... surgery was not performed. , The final study group ... and 17 receiving non-surgical therapy. Of the non-surgery group, ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... significant number of healthcare providers are using some form of complementary ... or they have introduced certain facets of alternative medicine into their ... ... 2008 -- As more consumers become aware of medical alternatives to ...
... decades, researchers have dreamed of creating robots with human-like abilities. Now ... and hand that moves and 'senses' like a human, and is ... far behind? , ... (PRWEB) July 23, 2008 -- ...
... provides permanent, natural looking results, says Dr. Michael Law a board ... into fat injections and the role of lipostructure in facial plastic ... provides natural beautiful and permanent results by restoring a youthful but ... ...
... Extraordinary Global Effort, Project Calls for ... 23 The Medpedia Project,today announced the ... of medicine called Medpedia. Physicians, medical schools,hospitals, ... now,volunteering to collaboratively build the most comprehensive ...
... tested, patient,s treatment and prognosis may be affected, study ... with stomach or pancreatic cancer may have more lymph ... treated at designated comprehensive cancer centers or at hospitals ... a U.S. study. , If too few lymph nodes ...
... of more than 16,000 members dedicated to promoting ... imaging and nuclear medicinehas awarded $170,000 in research ... research. The awards, supported by SNM,s Education and ... Meeting, held in New Orleans, La. , ...
Cached Medicine News:Health News:Eastern and Western Medicine Meet in Medical Offices 2Health News:Eastern and Western Medicine Meet in Medical Offices 3Health News:Eastern and Western Medicine Meet in Medical Offices 4Health News:Eastern and Western Medicine Meet in Medical Offices 5Health News:Sensitive, Smart and Strong - Too Bad it's Just a Robotic Arm 2Health News:Sensitive, Smart and Strong - Too Bad it's Just a Robotic Arm 3Health News:Sensitive, Smart and Strong - Too Bad it's Just a Robotic Arm 4Health News:Fat Grafting Provides Permanent, Natural Looking Results - Dr. Michael Law Explains Fat Injections as a New Trend in Facial Plastic Surgery 2Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 2Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 3Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 4Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 5Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 6Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 7Health News:Medpedia Announced, World's Largest Collaborative Online Encyclopedia of Medicine and Health 8Health News:More Cancer Lymph Nodes Analyzed at Specialty Centers 2Health News:Seeding the future: SNM grants grow molecular imaging and nuclear medicine research 2Health News:Seeding the future: SNM grants grow molecular imaging and nuclear medicine research 3
... The SEA 2000 Electrophoresis Apparatus (patented) provides ... DNA and RNA electrophoresis., In combination with ... 2000 covers applications that require a regular ... system., With the SEA 2000 it is ...
... Submerged horizontal gels offer many advantages ... a primary tool for the molecular biologist. ... readily dissipate heat. These gels allow sample ... by wicks or sample well dehydration. Horizontal ...
... The Mini-Sub cell GT system for ... acids in agarose gels includes a ... electrodes, a 7 x 7 cm ... two casting gates, and two 1.5 ...
... The DryEase Mini-Gel Drying System is a simple ... evaporation. The kit allows gels to be assembled ... both outer surfaces of the gels are exposed ... is minimized. The proprietary Gel-Dry™ Drying Solution modulates ...
Medicine Products: